<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001183</url>
  </required_header>
  <id_info>
    <org_study_id>820032</org_study_id>
    <secondary_id>82-H-0032</secondary_id>
    <nct_id>NCT00001183</nct_id>
  </id_info>
  <brief_title>Evaluation of the Causes and Disease Processes of Chronic Lung Disease</brief_title>
  <official_title>Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic lung diseases are disorders associated with abnormalities in any of the structures&#xD;
      involved in the process of breathing and bringing oxygen into the lungs and blood. This&#xD;
      includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the&#xD;
      tissue covering the lungs (pleura).&#xD;
&#xD;
      The purpose of this research study is to evaluate patients referred to the Cardiovascular and&#xD;
      Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to;&#xD;
&#xD;
        1. Develop a better understanding of the causes and disease processes involved in disorders&#xD;
           of the lungs&#xD;
&#xD;
        2. Identify patients eligible to participate in other P-CCMB research studies&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The chronic lung diseases are those disorders associated with functional and/or structural&#xD;
      derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or&#xD;
      mediastinum. The purpose of this project is to permit the comprehensive evaluation of&#xD;
      patients referred to the Pulmonary Branch of the National Heart, Lung, and Blood Institute&#xD;
      (NHLBI) in order to: (1) develop an understanding of the etiology and pathogenesis of these&#xD;
      disorders; and (2) identify individuals who will be suitable candidates for other NHLBI&#xD;
      protocols. Testing and procedures will only be performed when medically indicated for the&#xD;
      purposes of making a diagnosis or obtaining information likely to be useful in the management&#xD;
      of the subjects' disease or condition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 18, 1984</start_date>
  <completion_date type="Actual">December 16, 2019</completion_date>
  <primary_completion_date type="Actual">December 16, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>N/A-screening protocol</measure>
    <time_frame>1 Visit</time_frame>
    <description>Evaluate</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6564</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Pulmonary Patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients being screened for lung disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        Symptoms consistent with pulmonary disease.&#xD;
&#xD;
        May have family history of lung disease.&#xD;
&#xD;
        Patients with diseases of organs with known association with lung disease.&#xD;
&#xD;
        Ranging in age from 7 to 90 years old.&#xD;
&#xD;
        Pregnant and nursing women may participate in minimal risk procedures&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
        Persons with no clinical evidence of lung disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Moss, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart, Lung, and Blood Institute (NHLBI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_1982-H-0032.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <verification_date>May 2022</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>May 27, 2022</last_update_submitted>
  <last_update_submitted_qc>May 27, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Computed Tomography</keyword>
  <keyword>Fiberoptic Bronchoscopy</keyword>
  <keyword>Pulmonary Function Testing</keyword>
  <keyword>Cardiopulmonary Exercise Testing</keyword>
  <keyword>Allergen Skin Testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

